Legal - Pharmaceutical Executive


New legislation, key court cases, and trends affecting patents, marketing, privacy, product liability, and more.

Pay for Delay?

October 1, 2013

Europe follows the United States with a harsh new spotlight on agreements that slow generic entry for medicines losing exclusivity.

Fortuity and the First Amendment

February 1, 2013

Caronia decision shows the staying power of Sorrell v. IMS Health.

Product Liability Claims and Comment K

January 1, 2013

Courts across the country are making it easier to prove that a drug is unsafe, warning label notwithstanding.

Defensible Data Disposal

October 1, 2012

With the costs of data storage poised to increase, pharmaceutical companies need to break their pack rat mentality with respect to data, writes Lorrie Luellig.

Judging a Pill by its Cover

March 1, 2012

Pharmaceutical trade dres is an effective marketing tool that helps boost product recognition for consumers. It's worth protecting.

Money for Nothing, Patents for Free?

February 1, 2012

State tech transfer laws giving universities automatic ownership of employees' inventions represent a threat to pharma partnerships—but the Supreme Court is poised to intervene in the industry's favor.

Compliance: Getting Those Ducks in a Row

January 1, 2012

Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.

Seeing the Fire Behind the Smoke

July 1, 2011

Structuring a good deal depends on understanding your partner—and a high degree of specificity

Expanded Liability for Generic, Brand Manufacturers Ahead?

May 1, 2011

To what extent are generics companies obligated by law to request labeling changes with FDA?


Click here